Phase 1 Glioma Glioblastoma Multiforme Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1Phase 2

Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss

Lung CancerNon-small Cell Lung CancerSolid Tumor+4 more

Tango Therapeutics, Inc.191 enrolled15 locationsNCT06810544

Recruiting

Phase 1

Phase 1 Open-label Study of 123I-ATT001 in Subjects with Relapsed Glioblastoma

Glioma Glioblastoma Multiforme

Theragnostics Ltd67 enrolled2 locationsNCT06650605